Magnetar Financial’s Orion Biotech Opportunities Corp. Units ORIAU Stock Holding History

Magnetar Financial’s Portfolio ORIAU Stock Details ORIAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-492,000	Closed	-$4.86K	–	1795
2022 Q2	$4.86K	Sell	492,000 -84,000	-15%	-$825K	0.05%	322
2022 Q1	$5.94M	Sell	576,000 -24,000	-4%	-$236K	0.06%	301
2021 Q4	$5.94M	Hold	600,000	–	–	0.06%	330
2021 Q3	$6M	Hold	600,000	–	–	0.06%	315
2021 Q2	$6.06K	Buy	+600,000	New	+$6.05M	0.06%	324

Other funds holding ORIAU

JNE Partners London, United Kingdom $244M AUM 15.73% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SMA

Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Magnetar Financial's ORIAU Position: Q3 2022 in Review

Magnetar Financial sold out of Orion Biotech Opportunities Corp. Units (ORIAU) in Q3 2022, closing a stake of 492,000 shares — an estimated $4.86K sold.

Magnetar Financial first reported a position in ORIAU in Q2 2021 and held it in 5 quarters. The position peaked at $6M in Q3 2021. 11 funds tracked by Wall St. Rank hold ORIAU as of Q3 2022.

Magnetar Financial reported no remaining Orion Biotech Opportunities Corp. Units position as of Q3 2022 after selling out during the quarter.
Magnetar Financial sold 492,000 Orion Biotech Opportunities Corp. Units shares in Q3 2022, an estimated $4.86K.
Magnetar Financial first reported a position in Orion Biotech Opportunities Corp. Units in Q2 2021 and held it in 5 quarters.
Magnetar Financial's Orion Biotech Opportunities Corp. Units position peaked at $6M in Q3 2021.
11 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Units as of Q3 2022.

Based on Magnetar Financial's 13F filing for Q3 2022, filed 14 Nov 2022.